ExeVir is a clinical stage company developing single-domain antibody-based therapies that help patients ward off viral infections. Our lead candidate XVR011 is in accelerated development as a COVID-19 therapeutic.
There are
11 – 50
employees in the company
Offices
The company has it office headquartered in Belgium.